Argentina
Colombia
Malaysia
Mexico
Other LatAm Countries
English
-
-
Dengue in the Midst of COVID-19 Pandemic
ADVA14 minutes -
The Shifting Epidemiology of Dengue: From Climate Change to Urbanization
Medscape5 minutes -
Dengue disease awareness
ISID39 minutes -
What is the diagnosis? - Challenging Pediatric ID Cases in Dengue Endemic Regions
WSPID59 minutes -
Controlling Dengue: Immunization Is a Pillar of Prevention
Medscape33 minutes -
Emerging Issues in Dengue Control
Takeda -
Dengue Prevention: Vaccination as Part of A Comprehensive Strategy for Disease Control
Takeda -
Dengue Vaccines
Takeda -
Experience of a tertiary hospital in Singapore managing a dual outbreak of COVID and dengue
Takeda2 minutes -
Case report: Acute vision loss in a young returning traveler with dengue fever
Takeda2 minutes -
Covid-19 and dengue: Double punches for dengue-endemic countries in Asia
Takeda2 minutes -
First autochthonous dengue outbreak in Italy, August 2020
Takeda2 minutes -
Dengue is the most common non-malarial febrile illness in Southern Asia and Southeastern Asia
Takeda2 minutes -
When fever is not malaria in Latin America
Takeda2 minutes -
Dengue Vectors
Takeda5 minutes -
Vector control
Takeda4 minutes -
Surveillance and Reporting
Takeda5 minutes -
Dengue Phases & Guidelines
Takeda4 minutes -
Antibody Levels over Time
Takeda2 minutes -
Laboratory diagnostic tests
Takeda -
Differential diagnosis
Takeda1 minutes -
Dengue disease states
Takeda4 minutes -
Burden of Dengue
Takeda38 minutes -
Challenges in the management and diagnosis of Zika, Dengue and Chikungunya
Takeda42 minutes -
Clinical diagnosis and management of dengue
PAHO -
Randomised trials of Wolbachia for dengue control – a step towards elimination?
ADVA50 minutes -
Impact of the COVID-19 Pandemic on the Global Dengue Situation
ADVA79 minutes -
Dengue Clinical Case Management
CDC -
The global trends and regional differences in incidence of dengue infection from 1990 to 2019: An analysis from the Global Burden of Disease Study 2019
Takeda2 minutes -
Emerging Issues in Pediatric Dengue
WSPID50 minutes -
Antibody-dependent enhancement of severe dengue disease in humans
Takeda2 minutes -
Dengue: diagnosis and treatment updates
ISID62 minutes -
Resources for patient support
Takeda3 minutes -
Dengue fever and insecticide resistance in Aedes mosquitoes in Southeast Asia: a review
Takeda2 minutes -
Causes of fever in returning travelers: A European multicenter prospective cohort study
Takeda2 minutes -
Dengue diagnosis: unique challenges in a time of a pandemic
Medscape15 minutes -
Professor Adi Utarini – Eliminating Dengue
35 minutes -
Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes
Takeda2 minutes -
Dengue vector control: what works best
WSPID20 minutes -
Mosquito Longevity
ADVA22 minutes -
Dengue Prevention: Translating Knowledge into Action
Takeda -
Zika and dengue but not chikungunya are associated with Guillain–Barré syndrome in Mexico: A case-control study
Takeda2 minutes
Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda
This website is intended for informational purposes only and is not a substitute for healthcare professional’s clinical knowledge or professional judgment.
© Copyright 2025 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2023